RICHTMANN, Sarah, WILKENS, Dennis, WARTH, Arne, LASITSCHKA, Felix, WINTER, Hauke, CHRISTOPOULOS, Petros, HERTH, Felix, MULEY, Thomas, MEISTER, Michael und SCHNEIDER, Marc, 2019. FAM83 A and FAM83 B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC. Basel: MDPI.
Elsevier - Harvard (with titles)Richtmann, S., Wilkens, D., Warth, A., Lasitschka, F., Winter, H., Christopoulos, P., Herth, F., Muley, T., Meister, M., Schneider, M., 2019. FAM83 A and FAM83 B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC, Cancers. MDPI, Basel. https://doi.org/10.26083/tuprints-00015874
American Psychological Association 7th editionRichtmann, S., Wilkens, D., Warth, A., Lasitschka, F., Winter, H., Christopoulos, P., Herth, F., Muley, T., Meister, M., & Schneider, M. (ca. 2019). FAM83 A and FAM83 B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC [Cd]. In Cancers. MDPI. https://doi.org/10.26083/tuprints-00015874
Springer - Basic (author-date)Richtmann S, Wilkens D, Warth A, Lasitschka F, Winter H, Christopoulos P, Herth F, Muley T, Meister M, Schneider M (2019) FAM83 A and FAM83 B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC. MDPI, Basel
Juristische Zitierweise (Stüber) (Deutsch)Richtmann, Sarah/ Wilkens, Dennis/ Warth, Arne/ Lasitschka, Felix/ Winter, Hauke/ Christopoulos, Petros/ Herth, Felix/ Muley, Thomas/ Meister, Michael/ Schneider, Marc, FAM83 A and FAM83 B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC, Basel 2019.